Key facts
- It has raised $41.6M across 1 recorded rounds; the latest was Early Stage VC ($12.5M) in Apr 2023.
- Notable investors include NewSpring Capital, Nueterra Capital, Croft & Bender, Blue Hour Ventures, K2X.
- Patheous Health has filed 2 Form Ds with the SEC since 2020, most recently Apr 2023 ($12.5M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Patheous Health
Funding rounds
1 roundsAbout Patheous Health
Developer of a mobile dysphagia swallow imaging device designed to improve dysphagia healthcare and education for healthcare clinicians. The company's device provides comprehensive healthcare services for the management of dysphagia in the aging senior population, enabling medical professionals to manage the rapidly growing senior population effectively.
- Sector
- Healthcare
- HQ
- Overland Park, KS, United States
- Founded
- 2019
- Employees
- 116
- Website
- patheoushealth.com/
- Ownership
- Privately Held (backing)
Patheous Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Patheous Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Patheous Health in its N-PORT filings yet. We sweep new filings monthly.